Loading
PDBj
MenuPDBj@FacebookPDBj@TwitterPDBj@YouTubewwPDB FoundationwwPDB
RCSB PDBPDBeBMRBAdv. SearchSearch help

7KCO

ROR gamma in complex with SCR2 and compound 3

Summary for 7KCO
Entry DOI10.2210/pdb7kco/pdb
DescriptorNuclear receptor ROR-gamma, Peptide GLU-LYS-HIS-LYS-ILE-LEU-HIS-ARG-LEU-LEU-GLN-ASP-SER, 1-[(2-chlorophenyl)methyl]-N-{[4-(methylsulfonyl)phenyl]methyl}-4',5'-dihydrospiro[piperidine-4,7'-thieno[2,3-c]pyran]-2'-carboxamide, ... (5 entities in total)
Functional Keywordsinhibitor, signaling protein
Biological sourceHomo sapiens (Human)
More
Total number of polymer chains4
Total formula weight62104.97
Authors
Durbin, J.D.,Guo, S.Y.,Stout, S.L.,Clawson, D.K. (deposition date: 2020-10-06, release date: 2021-04-21, Last modification date: 2024-04-03)
Primary citationLugar, C.W.,Clarke, C.A.,Morphy, R.,Rudyk, H.,Sapmaz, S.,Stites, R.E.,Vaught, G.M.,Furness, K.,Broughton, H.B.,Durst, G.L.,Clawson, D.K.,Stout, S.L.,Guo, S.Y.,Durbin, J.D.,Stayrook, K.R.,Edmondson, D.D.,Kikly, K.,New, N.E.,Bina, H.A.,Chambers, M.G.,Shetler, P.,Chang, W.Y.,Chang, V.C.,Barr, R.,Gough, W.H.,Steele, J.P.,Getman, B.,Patel, N.,Mathes, B.M.,Richardson, T.I.
Defining Target Engagement Required for Efficacy In Vivo at the Retinoic Acid Receptor-Related Orphan Receptor C2 (ROR gamma t).
J.Med.Chem., 64:5470-5484, 2021
Cited by
PubMed Abstract: The Th17 pathway has been implicated in autoimmune diseases. The retinoic acid receptor-related orphan receptor C2 (RORγt) is a master regulator of Th17 cells and controls the expression of IL-17A. RORγt is expressed primarily in IL-17A-producing lymphoid cells. Here we describe a virtual screen of the ligand-binding pocket and subsequent screen in a binding assay that identified the 1-benzyl-4',5'-dihydrospiro[piperidine-4,7'-thieno[2,3-]pyran]-2'-carboxamide scaffold as a starting point for optimization of binding affinity and functional activity guided by structure-based design. Compound demonstrated activity in a mouse PK/PD model and efficacy in an inflammatory arthritis mouse model that were used to define the level and duration of target engagement required for efficacy . Further optimization to improve ADME and physicochemical properties with guidance from simulations and modeling provided compound , which is projected to achieve the level and duration of target engagement required for efficacy in the clinic.
PubMed: 33852312
DOI: 10.1021/acs.jmedchem.0c01918
PDB entries with the same primary citation
Experimental method
X-RAY DIFFRACTION (1.86 Å)
Structure validation

227111

數據於2024-11-06公開中

PDB statisticsPDBj update infoContact PDBjnumon